Fujifilm India Installs 125 AMULET Innovality Digital Mammography Machines Across India

New Delhi : FUJIFILM India, a leading pioneer in advancing healthcare imaging technologies, has achieved a significant milestone by deploying 125 AMULET Innovality digital mammography machines across India, marking a noteworthy advancement in the field of digital mammography. This achievement underscores the company’s commitment to enhancing the fight against breast cancer and expanding its installation base continually.

According to Globocan data from 2020, breast cancer constituted 13.5% (178,361 cases) of all cancer diagnoses and 10.6% (90,408 cases) of all cancer-related deaths in India. These statistics emphasize the critical importance of early breast cancer detection in improving survival rates.

As reported by IndiaEducationDiary.com, FUJIFILM India believes it has a societal obligation to raise awareness about early breast cancer detection and equip healthcare professionals with cutting-edge technologies to better serve the community. To further this mission, the ‘Together Against Breast Cancer’ conference was held in Goa from September 15th to 17th, 2023.

Koji Wada, Managing Director, FUJIFILM India said, “At FUJIFILM India, our unwavering commitment to women’s health is exemplified by the technologies we bring and the advocacy we do for early diagnosis. The installation of 125 AMULET Innovality digital mammography machines across India are a testament to our dedication to enhance healthcare infrastructure for the early detection of breast cancer. However, I strongly feel that 125 is just a milestone in this journey and we will be expanding our installation base with a very fast pace in the near future. Beyond our advancements in healthcare technology, our ‘Together Against Breast Cancer’ Conference is proudly celebrating its 3rd edition, reinforcing our commitment to raising awareness. We firmly believe that improving access to technology and increasing awareness are pivotal steps toward fostering a healthier India”.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward